ANTI-pY1235-MET IMMUNOLOGICAL BINDING REAGENT Read more about ANTI-pY1235-MET IMMUNOLOGICAL BINDING REAGENT US Patent 11,340,219Filed on 2018-09-17
ANTI-PY1235-MET IMMUNOLOGICAL BINDING REAGENT Read more about ANTI-PY1235-MET IMMUNOLOGICAL BINDING REAGENT European Patent17714118.1Filed on 2018-10-01
M971 Chimeric Antigen Receptors Read more about M971 Chimeric Antigen Receptors Australia2018204257Filed on 2018-06-14
Murine Anti-NY-ESO-1 T Cell Receptors Read more about Murine Anti-NY-ESO-1 T Cell Receptors Hong Kong18111203.0Filed on 2018-08-31
COMBINATION OF HISTONE DEACETYLASE INHIBITOR AND IMMUNOTHERAPY Read more about COMBINATION OF HISTONE DEACETYLASE INHIBITOR AND IMMUNOTHERAPY US Application 16/066,693Filed on 2018-06-28
COMBINATION OF HISTONE DEACETYLASE INHIBITOR AND IMMUNOTHERAPY Read more about COMBINATION OF HISTONE DEACETYLASE INHIBITOR AND IMMUNOTHERAPY European Patent17702441.1Filed on 2018-07-04
TARGETED CANCER THERAPY Read more about TARGETED CANCER THERAPY BrazilBR112018008783-1Filed on 2016-10-28
TARGETED CANCER THERAPY Read more about TARGETED CANCER THERAPY Australia2016343722Filed on 2016-10-28
ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS Read more about ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS Patent Cooperation TreatyPCT/US2018/039917Filed on 2018-06-28
ANTI-TNF INDUCED APOPTOSIS (ATIA) DIAGNOSTIC MARKERS AND THERAPIES Read more about ANTI-TNF INDUCED APOPTOSIS (ATIA) DIAGNOSTIC MARKERS AND THERAPIES US Application 15/997,477Filed on 2018-06-04